CT
Caspian Therapeutics, Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$50Msold at filing
Total offering$50M
Investors in the raise43count reported to the SEC
FiledSep 23, 2026first sale Sep 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Robert H. SpencerExecutive Officer
Troy E. WilsonDirector
Spike E. LoyDirector
Executive officers, directors and promoters as listed on the Form D.